Trismus and reduced quality of life in patients with oral squamous cell carcinoma, who received post-operative radiotherapy alone or combined with chemotherapy

[1]Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European J Cancer 2013;49:1374-1403.10.1016/j.ejca.2012.12.027FerlayJSteliarova-FoucherELortet-TieulentJRossoSCoeberghJWWComberHCancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European J Cancer2013491374140323485231Open DOISearch in Google Scholar

[2]Citrin D, Mansueti J, Likhacheva A, Sciuto L, Albert PS, Rudy SF, et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiation Oncology Biol Phys 2009;74:1040-1046.10.1016/j.ijrobp.2008.09.053CitrinDMansuetiJLikhachevaASciutoLAlbertPSRudySFLong-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerInt J Radiation Oncology Biol Phys20097410401046272082419117692Open DOISearch in Google Scholar

[3]Cartmill B, Cornwell P, Ward E, Davidson W, Porceddu S. Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1-T3 oropharyngeal cancer. Support Care Cancer 2012;20:2073-2081.2208120610.1007/s00520-011-1316-4CartmillBCornwellPWardEDavidsonWPorcedduS.Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1-T3 oropharyngeal cancerSupport Care Cancer2012202073208122081206Search in Google Scholar

[4]Chera BS, Eisbruch A, Murphy BA, et al. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. J Natl Cancer Inst 2014;106:1-4.CheraBSEisbruchAMurphyBARecommended patient-reported core set of symptoms to measure in head and neck cancer treatment trialsJ Natl Cancer Inst20141061410.1093/jnci/dju127419204325006189Search in Google Scholar

[5]Citak E, Tulek Z. Longitudinal quality of life in Turkish patients with head and neck cancer undergoing radiotherapy. Support Care Cancer 2013;21:2171-2183.2347519510.1007/s00520-013-1774-yCitakETulekZ.Longitudinal quality of life in Turkish patients with head and neck cancer undergoing radiotherapySupport Care Cancer2013212171218323475195Search in Google Scholar

[6]Lee LY, Chen SC, Chen WC, Huang BS, Lin CY. Post radiation trismus and its impact on quality of life in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:187-195.10.1016/j.oooo.2014.10.003LeeLYChenSCChenWCHuangBSLinCY.Post radiation trismus and its impact on quality of life in patients with head and neck cancerOral Surg Oral Med Oral Pathol Oral Radiol201511918719525487985Open DOISearch in Google Scholar

[7]Reeve BB, Cai J, Zhang H, Weissler MC, Wisniewski K, Gross H, et al. Factors that impact health-related quality of life over time for individuals with head and neck cancer. Laryngoscope 2016;126:2718-2725.2722402410.1002/lary.26073ReeveBBCaiJZhangHWeisslerMCWisniewskiKGrossHFactors that impact health-related quality of life over time for individuals with head and neck cancerLaryngoscope20161262718272527224024Search in Google Scholar

[8]Rigoni L, Bruhn RF, De Cicco R, Kanda JL, Matos LL. Quality of life impairment in patients with head and neck cancer and their caregivers: a comparative study. Braz J Otorhinolaryngol. 2016;82:680-686.10.1016/j.bjorl.2015.12.01227133907RigoniLBruhnRFDe CiccoRKandaJLMatosLL.Quality of life impairment in patients with head and neck cancer and their caregivers: a comparative studyBraz J Otorhinolaryngol.20168268068627133907Open DOISearch in Google Scholar

[9]Hsieh LC, Chen JW, Wang LY, Tsang YM, Shueng PW, Liao LJ, et al. Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging. PLOS ONE2014;9:e92561, 1-8.10.1371/journal.pone.009256124658376HsiehLCChenJWWangLYTsangYMShuengPWLiaoLJPredicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imagingPLOS ONE20149e9256118396241824658376Open DOISearch in Google Scholar

[10]Van der Molen L, Heemsbergen WD, de Jong R, van Rossum MA, Smeele LE, Rasch CRN, et al. Dysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. Radiotherapy and Oncology 2013;106:364-369.10.1016/j.radonc.2013.03.005Van der MolenLHeemsbergenWDde JongRvan RossumMASmeeleLERaschCRNDysphagia and trismus after concomitant chemo-intensity-modulated radiation therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structuresRadiotherapy and Oncology201310636436923540551Open DOISearch in Google Scholar

[11]Gebre-Medhin M, Haghanegi M, Robert L, Kjellen E, Nilsson P. Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncologica 2016;55:1313-1317.10.1080/0284186X.2016.1221129Gebre-MedhinMHaghanegiMRobertLKjellenENilssonP.Dose-volume analysis of radiation-induced trismus in head and neck cancer patientsActa Oncologica20165513131317Open DOISearch in Google Scholar

[12]Wetzels J-W GH, Merkx MAW, de HaanAJ, Koole R, Speksnijder CM. Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective study. Head & Neck 2014;36:1754-1762.2447821710.1002/hed.23534WetzelsJ-W GHMerkxMAWde HaanAJKooleRSpeksnijderCM.Maximum mouth opening and trismus in 143 patients treated for oral cancer: a 1-year prospective studyHead & Neck20143617541762Search in Google Scholar

[13]Steiner F, Evans J, Marsh P, Rigby P, James S, Sutherland K, et al. Mouth opening and trismus in patients undergoing curative treatment for head and neck cancer. Int J Oral Maxillofac Surg 2015;44:292-296.2557766410.1016/j.ijom.2014.12.009SteinerFEvansJMarshPRigbyPJamesSSutherlandKMouth opening and trismus in patients undergoing curative treatment for head and neck cancerInt J Oral Maxillofac Surg201544292296Search in Google Scholar

[14]Rodrigues A, Kondo C A, Procópio AS, Gualberto J. Helkimo and craniomandibular indices in the classification of temporomandibular disorders. A Comparative Study. MYOPAIN 2016;1:1-6.RodriguesAKondoC AProcópioASGualbertoJ.Helkimo and craniomandibular indices in the classification of temporomandibular disordersA Comparative Study. MYOPAIN2016116Search in Google Scholar

[15]Dijkstra PU, Huisman PM, Roodenburg JLN. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35:337-342.10.1016/j.ijom.2005.08.00116280237DijkstraPUHuismanPMRoodenburgJLN.Criteria for trismus in head and neck oncologyInt J Oral Maxillofac Surg200635337342Open DOISearch in Google Scholar

[16]Spijkervet FKL, Van Saene HKF, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 1989;18:176-171.SpijkervetFKLVan SaeneHKFPandersAKVermeyAMehtaDM.Scoring irradiation mucositis in head and neck cancer patientsJ Oral Pathol Med19891817617110.1111/j.1600-0714.1989.tb00756.xSearch in Google Scholar

[17]Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.10.1093/jnci/85.5.3658433390AaronsonNKAhmedzaiSBergmanBBullingerMCullADuezNJThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst199385365376Open DOISearch in Google Scholar

[18]Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ –C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 2000;36:1796-1807.10.1016/S0959-8049(00)00186-610974628BjordalKde GraeffAFayersPMHammerlidEvan PottelsbergheCCurranDA 12 country field study of the EORTC QLQ –C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patientsEur J Cancer20003617961807Open DOISearch in Google Scholar

[19]Singer S, Araujo C, ArrarasJI, Baumann I, Boehm A, Brokstad Herlofson B, et al. Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N module, Phase III. Head & Neck 2015;37:1358-1367.10.1002/hed.2376224832623SingerSAraujoCArrarasJIBaumannIBoehmABrokstad HerlofsonBMeasuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N module, Phase IIIHead & Neck20153713581367Open DOISearch in Google Scholar

[20]Oken MM, Creech RH, Tormey DC, Horton J. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.10.1097/00000421-198212000-000147165009OkenMMCreechRHTormeyDCHortonJ.Toxicity and response criteria of the Eastern Cooperative Oncology GroupAm J Clin Oncol19825649655Open DOISearch in Google Scholar

[21]Mezitis M, Rallis G, Zachariades N. The normal range of mouth opening. J Oral Maxillofac Surg 1989;47:1028-1029.10.1016/0278-2391(89)90174-22795295MezitisMRallisGZachariadesN.The normal range of mouth openingJ Oral Maxillofac Surg19894710281029Open DOISearch in Google Scholar

[22]Gallagher C, Gallagher V, Whelon H, Cronin M. The normal range of mouth opening in an Irish population. J Oral Rehab 2004;31:110-116.10.1046/j.0305-182X.2003.01209.xGallagherCGallagherVWhelonHCroninM.The normal range of mouth opening in an Irish populationJ Oral Rehab200431110116Open DOISearch in Google Scholar

[23]Khare N, Patil SB, Kale SM, Sumeet J, Sonali I, Sumeet B. Normal mouth opening in an adult Indian population. J Maxillofac Oral Surg 2012;11:309-313.10.1007/s12663-012-0334-1KhareNPatilSBKaleSMSumeetJSonaliISumeetB.Normal mouth opening in an adult Indian populationJ Maxillofac Oral Surg201211309313342845823997482Open DOISearch in Google Scholar

[24]Nicolatou-Galitis O, Sarri T, Dardoufas K, Kouloulias V, Sotiropoulou-Lontou A, Vakalsi X, et al. Oral mucositis, pain and xerostomia in patients with head and neck cancer who received chemoradiotherapy with or without cetuximab. The Open Clinical Cancer J 2010;4:6-14.10.2174/1874189401004010006Nicolatou-GalitisOSarriTDardoufasKKoulouliasVSotiropoulou-LontouAVakalsiXOral mucositis, pain and xerostomia in patients with head and neck cancer who received chemoradiotherapy with or without cetuximabThe Open Clinical Cancer J20104614Open DOISearch in Google Scholar

[25]Nicolatou-Galitis O, Kouloulias V, Sotiropoulou-Lontou A, Dardoufas K, Polychronopoulou A, Athanassiadou P, et al. Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy. The Open Cancer J 2011;4:7-17.10.2174/1874079001104010007Nicolatou-GalitisOKoulouliasVSotiropoulou-LontouADardoufasKPolychronopoulouAAthanassiadouPOral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapyThe Open Cancer J20114717Open DOISearch in Google Scholar

[26]Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010;18:1039-1060.2023780510.1007/s00520-010-0827-8JensenSBPedersenAMLVissinkAAndersenEBrownCGDaviesANA systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of lifeSupport Care Cancer2010181039106020237805Search in Google Scholar

[27]Loorents V, Rosell J, Salgado H, Borjeson S. Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC). SpringerPlus 2016; 10.1186/s40064-016-2295-1.27347463LoorentsVRosellJSalgadoHBorjesonS.Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC)SpringerPlus201610.1186/s40064-016-2295-1489933927347463Open DOISearch in Google Scholar

[28]Pauli N, Johnson J, Finizia K, Andrell P. The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer. Acta Oncologica 2013;52:1137-1145.10.3109/0284186X.2012.744466PauliNJohnsonJFiniziaKAndrellP.The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancerActa Oncologica2013521137114523193958Open DOISearch in Google Scholar

[29]Van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CRN, Hilgers FJM. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemotherapy: Feasibility, compliance, and short-term effects. Dysphagia 2011;26:155-170.2062330510.1007/s00455-010-9288-yVan der MolenLvan RossumMABurkheadLMSmeeleLERaschCRNHilgersFJM.A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemotherapy: Feasibility, compliance, and short-term effectsDysphagia201126155170309897620623305Search in Google Scholar

[30]Pauli N, Fagerberg-Mohlin B, AndrellP, Finizia C. Exercise intervention for the treatment of trismus in head and neck cancer. Acta Oncologica 2014;53:502-509.10.3109/0284186X.2013.837583PauliNFagerberg-MohlinBAndrellPFiniziaC.Exercise intervention for the treatment of trismus in head and neck cancerActa Oncologica20145350250924175896Open DOISearch in Google Scholar

[31]Loorents V, Rossel J, Karlsson C, Lidback M, Hultman K, Borjeson S. Prophylactic training for the prevention of radiotherapy-induced trismus - a randomized study. Acta Odontologica 2014;53:530-538.LoorentsVRosselJKarlssonCLidbackMHultmanKBorjesonS.Prophylactic training for the prevention of radiotherapy-induced trismus - a randomized studyActa Odontologica20145353053810.3109/0284186X.2014.89221124635110Search in Google Scholar

[32]Kamstra JI, Reintsema H, Roodenburg JLN, Dijkstra PU. Dynasplint trismus system exercises for trismus secondary to head and neck cancer: a prospective explorative study. Support Care Cancer 2016;24:3315-3323.2695671310.1007/s00520-016-3131-4KamstraJIReintsemaHRoodenburgJLNDijkstraPU.Dynasplint trismus system exercises for trismus secondary to head and neck cancer: a prospective explorative studySupport Care Cancer20162433153323491758426956713Search in Google Scholar

[33]Func CS, Warmling CM, Baldisserotto J. A randomized clinical trial to evaluate the impact of a dental care program in the quality of life of head and neck cancer patients. Clin Oral Invest 2013. 10.1007/s00784-013-1068-2.FuncCSWarmlingCMBaldisserottoJ.A randomized clinical trial to evaluate the impact of a dental care program in the quality of life of head and neck cancer patientsClin Oral Invest201310.1007/s00784-013-1068-223989505Open DOISearch in Google Scholar